BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Konu YR, Gbeasor-Komlanvi FA, Yerima M, Sadio AJ, Tchankoni MK, Zida-Compaore WIC, Nayo-Apetsianyi J, Afanvi KA, Agoro S, Salou M, Landoh DE, Nyansa AB, Boko E, Mijiyawa M, Ekouevi DK. Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021. Arch Public Health 2021;79:207. [PMID: 34819146 DOI: 10.1186/s13690-021-00741-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Terefa DR, Shama AT, Tekle E. Outcomes following COVID-19 vaccination and associated factors among healthcare professionals in Oromia region, Ethiopia. Hum Vaccin Immunother 2023;19:2167901. [PMID: 36703523 DOI: 10.1080/21645515.2023.2167901] [Reference Citation Analysis]
2 Najjar M, Albuaini S, Fadel M, Aljbawi A, AlAwad Y, Mohsen F. Impact of comorbidities on hospitalised Syrian patients with COVID-19: a retrospective study. BMJ Open 2023;13:e068849. [PMID: 36940947 DOI: 10.1136/bmjopen-2022-068849] [Reference Citation Analysis]
3 Govindapala D, Dhanaratna D, Senarath U, Lamabadusuriya D, Senaratne T, Wijenayake W, Wijewardena D, Nakkawita D, Kawyangana P, Kulasekara U, Silva AD, Fernando N. Reactogenicity and persistence of IgG antibodies against SARS-CoV-2 among recipients of ChAdOx1 nCoV-19 vaccine: A single center experience from Sri Lanka. Int J Health Sci (Qassim) 2023;17:36-43. [PMID: 36704495] [Reference Citation Analysis]
4 Segni MT, Demissie HF, Adem MK, Geleto AK, Kelkile MW, Sori BK, Heyi ML, Iticha DG, Bejiga GS, Guddisa AB, Sima YA, Amente LT, Bayisa DA, Hurisa MB, Jiru TK. Post COVID-19 vaccination side effects and associated factors among vaccinated health care providers in Oromia region, Ethiopia in 2021. PLoS One 2022;17:e0278334. [PMID: 36480564 DOI: 10.1371/journal.pone.0278334] [Reference Citation Analysis]
5 Adamu H, Lawal S, Bawa IA, Sani AM, Adamu AA. Prevalence and pattern of adverse events following COVID 19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria.. [DOI: 10.1101/2022.11.01.22281793] [Reference Citation Analysis]
6 Hamayoun M, Abdulrazak I, Farid M, Malik MR, Mohamud MF. Adverse events following introduction of the ChAdOx1 nCoV-19 vaccine in Somalia in 2021: findings from a fragile setting and implications for the future. IJID Regions 2022;4:47-52. [DOI: 10.1016/j.ijregi.2022.06.001] [Reference Citation Analysis]
7 Najjar M, Albuaini S, Fadel M, Group DC, Mohsen F. Covid-19 Vaccination Efficacy, Reported Side Effects, and Hesitancy Among the Syrian Population.. [DOI: 10.21203/rs.3.rs-1927000/v1] [Reference Citation Analysis]
8 Yesuf EA, Riad A, Sofi-mahmudi A, Sudhakar M, Mekonnen A, Endalkachew S, Mama F, Muhidin S, Ayele B, Yahya M, Usman A, Abafita J, Klugar M. Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study. Front Public Health 2022;10:937794. [DOI: 10.3389/fpubh.2022.937794] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Chaurasia B, Chavda V, Lu B, Garg K, Montemurro N. Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination. Brain Behav Immun Health 2022;22:100463. [PMID: 35496775 DOI: 10.1016/j.bbih.2022.100463] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Muluneh AG, Merid MW, Gelaye KA, Tilahun SY, Teshager NW, Abereha AY, Sugamo KS, Yimer MA, Kassa GM. More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia. IDR 2022;Volume 15:2409-16. [DOI: 10.2147/idr.s360605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Anjorin AA, Odetokun IA, Nyandwi JB, Elnadi H, Awiagah KS, Eyedo J, Abioye AI, Gachara G, Maisara AM, Razouqi Y, Yusuf Mohamud MF, Mhgoob ZE, Ajayi T, Ntirenganya L, Saibu M, Salako BL, Elelu N, Wright KO, Fasina FO, Mosbah R. Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa. Vaccines 2022;10:546. [DOI: 10.3390/vaccines10040546] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Manilgama SR, Hettiarachchi NM, Jayasinghe IK, De Silva ST, Jayalath T, Wanigaratne T, Rathnayake BP, Suganthan N, Sudarshan P, Pathirage M, Rajaratnam N, Senaratne G, Rajapaksha V, Wickramasinghe A, Ranaweera SPAL, Thilakarathna AHM, Kulaweera MTD. Adverse events following COVISHIELD (ChAdOx1nCoV-19) vaccination among health care workers in Sri Lanka; a multi-centre cross sectional survey.. [DOI: 10.1101/2022.01.26.22269788] [Reference Citation Analysis]